Thrombosis and Hemostasis Centers from 2003 to 2009. Demographic characteristics were
compared between whites (N=2002) and African-Americans (N=395) who had objectively diagnosed VTE. There is no overall population denominator in this study, so that the rate of VTE cannot be compared between races. However, in this study which included only patients with established VTE, the total number of VTE events was marginally but significantly greater among whites. Whites had more "DVT only" and more "DVT + PE" than African-Americans.
In contrast, African-Americans had about twice the rate of "PE only" compared with whites. 3 With respect to thrombophilia in this CDC study, Factor V Leiden occurred in 1.5% of African-Americans versus 14.7% of whites. The prothrombin gene mutation was present in only 0.3% of African-Americans compared with 3.6% of whites. Rates of the antiphospholipid syndrome and of deficiency of antithrombin, protein C, and protein S were similar in both groups. Other notable findings were that a higher proportion of African-Americans were female (71% versus 61%). African-Americans had a higher proportion of HIV and sickle cell disease, whereas whites had a higher proportion of surgery, trauma or infection. African-Americans also had a higher proportion of idiopathic DVT and idiopathic PE compared with whites, who more often had secondary, provoked VTE.
These findings about DVT versus PE rates, coupled the consistent observation about low rates of factor V Leiden and prothrombin gene mutation in African-Americans, raise several questions that recur when evaluating other studies of race and VTE. First, is DVT actually the same illness as PE, and can we justify lumping DVT and PE together under the umbrella of VTE? Second, is the biochemistry of venous thrombosis different in African-Americans compared with whites? Do African-Americans have venous thrombi that are less likely to adhere to the wall of the pelvic and deep leg veins and consequently more likely to embolize to 0.3% of African-Americans compared with 3.6% of whites. Rates of the antipho ho osp spho ho holi li lipi pi pid d d yndrome and of deficiency of antithrombin, protein C, and protein S were similar in both gr grou ou ups ps ps. . O O Oth th the e er n not ot ota ab able findings were that a high her er er p p proportion of Af Af A rica ca an-n-n-Am A ericans were female 7 71% % % versus 61 61%) %) %). A A Afr fric ic ican an an-A -A -Ame meri ri r c ca can n ns had d a a hig gh he e er p p pro ro opo po ort rtio io i n n of of H HIV IV IV a and nd d s s sic ickl kl le e e c ce cell ll ll d d dis is isea ea ase e e, wh wh her er e ea ea eas s wh wh hit it ites es h h had ad d a a h hig ig ghe h r r pr pr p op op opor or orti tion on n o o of f f s su surg rg rger ery y, y, tr t a au auma ma ma o or r r in in i f fe fect ct ctio io i n n n. Af Af fri ri r ca ca an-n-Am Am Amer er ric c can ans s s al al lso s had a higher r p p pro ro ropo po port rt rtio io on n of f f i i idi di diop op pat at athi hi ic c c DV DV DVT T T an an and d d id id di iop op opat a hi hi hic c c PE PE PE c c com om ompa pa pare re red d d wi wi with th t w w whi hi hite te tes, s, s, w who more the pulmonary arteries? Third, does the low rate of factor V Leiden and the prothrombin gene mutation in African-Americans in this CDC study provide at least a partial explanation for the divergent rates of PE and DVT that were observed?
Factor V Leiden confers resistance to activated protein C. The "Leiden Paradox", named and popularized by Henri Bounameaux of Geneva, Switzerland, 4 is that patients with VTE and factor V Leiden have a rate of "PE only" that is about half the rate of patients without factor V Leiden. This means that those patients with VTE who do not have factor V Leiden are more likely to suffer isolated PE (as compared with isolated DVT) than those who have inherited the genetic predisposition to VTE. Similar to factor V Leiden, certain acquired VTE risk factors also confer increased resistance to activated protein C and cause more isolated DVT than isolated PE. These include oral contraceptive use, pregnancy, the postpartum state, and obesity. 5 So far, we have addressed primarily "Nature," the genetic predisposition sorted by race, and its possible relationship to the anatomical location of the venous thrombosis (Table 1) .
However, to understand the profound connection between race and VTE, one must probe "Nurture" (acquired, environmentally important risk factors) ( Table 2 ) along with "Nature" (genetics).
Acquired risk factors for VTE and its pathophysiology (especially the interplay of inflammation, hypercoagulability, and endothelial injury) are similar to acute myocardial infarction and atherothrombosis. 6 They include obesity, hypertension, diabetes mellitus, cigarette smoking, and hypercholesterolemia. 7 Triggers for hospitalization for VTE also include certain conditions associated with an intense inflammatory state: infection, erythropoiesisstimulating agents, and blood transfusion. 8 One line of reasoning is that African-Americans constitute a minority population subjected to health disparities and at risk for a disproportionate also confer increased resistance to activated protein C and cause more isolated DV DV VT T T th th han an an i i iso so sola lated PE. These include oral contraceptive use, pregnancy, the postpartum state, and obesity. 5 So So So f f far ar r, we we e h h ha ave addressed primarily "Nat at atur ur u e e," the genetic c pr p ed d dis is isp p position sorted by race, an nd d d it i s possible le r r rel l lat tio io ions s shi hi hip p p to to to t the he e a a ana nato tom mic cal l loc ca at ti ion n n o of of t the he h v ven en no ou us s th th thro o omb mb bo os osis is ( ( (Ta Ta Tabl bl ble 1 1 1) . ).
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In this issue of Circulation, three large prospective study databases are examined to test the association of race with VTE. 10 The cohorts together accumulated an impressive 438,090 Given the variability in the design and magnitude of these cohorts, perhaps it is not surprising that the association of race with VTE in risk factor-adjusted models differed in each cohort. In the Cardiovascular Health Study, blacks had a statistically significant 81% excess rate of VTE than whites. In ARIC, blacks trended toward more VTE than whites, with a 21% excess rate of VTE, a difference that approached but that did not achieve statistical significance. When ARIC data were normalized for age and sex distribution, the racial difference became statistically significant. In REGARDS, blacks in the Southeast had a significantly higher VTE rate than whites, but this observation did not hold true in the rest of the United States.
There is, however, one big surprise. In contrast to prior epidemiologic studies, PE Given n th th the e va va vari riab ab abilit it ty y y in in i t t the he he de de d si i ign gn gn a a and nd nd m m mag ag agni ni nitu tude de de o o of f f th th thes es ese e co co coho ho hort rt rts, s, s, p p per er rha ha haps ps ps i it t t is i not incidence was not higher in blacks than whites in ARIC, the Cardiovascular Health Study, or
REGARDS.
Puzzlement results from trying to harmonize the results of three large epidemiologic studies with radically different designs. One fact does remain secure. We must concede that there are no unshakable tenets when studying the relationship between race and VTE.
Several fundamental questions emerge:
1. Can we continue to justify lumping VTE as a combination of DVT alone, PE alone, DVT presenting symptoms plus PE found incidentally, and PE presenting symptoms with DVT found incidentally? Or are these distinct illnesses?
2. Can we define race on the basis of how a subject self-identifies? 4. Can we devise a predictive epidemiologic model that guides us in the racial association with VTE by inventing a paradigm that integrates nature and nurture?
5. Can we reform our healthcare and socioeconomic systems to minimize disparities that lead to more hypertension, cigarette smoking, obesity, and diabetes among underserved groups and which, in turn, constitute a higher frequency of reversible risk factors for PE and DVT?
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Figuring out the association between race and VTE will lead to better understanding of PE, DVT, genetic predisposition, and acquired risk factors. We have many gaps to fill. The epidemiology of this problem is ripe for new ideas and unconventional approaches. Our overarching goal is to prevent PE and DVT. We have only scratched the surface of what we can achieve with promotion of heart healthy lifestyle and elimination of reversible VTE risk factors. 
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